Description
Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
Location: REDI (East Bay)
Please contact: James Nasman NasmanJ@sutterhealth.org about study Neutropenia
View study details on ClinicalTrials.gov
Principal Investigator
Co-Investigator(s)
Rajesh Behl, M.D., Oleg I. Krijanovski, M.D., Ph.D.
Recruitment Status
Active, Recruiting
Start Date
June 28, 2019